These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 25097154

  • 1. Macular function and morphologic features in juvenile stargardt disease: longitudinal study.
    Testa F, Melillo P, Di Iorio V, Orrico A, Attanasio M, Rossi S, Simonelli F.
    Ophthalmology; 2014 Dec; 121(12):2399-405. PubMed ID: 25097154
    [Abstract] [Full Text] [Related]

  • 2. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN, ProgStar Study Group.
    JAMA Ophthalmol; 2017 Jul 01; 135(7):696-703. PubMed ID: 28542693
    [Abstract] [Full Text] [Related]

  • 3. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P, Testa F, Rossi S, Di Iorio V, Orrico A, Auricchio A, Simonelli F.
    Invest Ophthalmol Vis Sci; 2016 Jul 01; 57(9):OCT247-52. PubMed ID: 27409479
    [Abstract] [Full Text] [Related]

  • 4. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB, Iacono P, Triolo G, La Spina C, Zucchiatti I, Cicinelli MV, Borrelli E, Manitto MP, Martina E, Bandello F.
    Br J Ophthalmol; 2015 Oct 01; 99(10):1354-9. PubMed ID: 25837607
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.
    Schönbach EM, Strauss RW, Muñoz B, Wolfson Y, Ibrahim MA, Birch DG, Zrenner E, Sunness JS, Ip MS, Sadda SR, West SK, Scholl HPN, ProgStar Study Group.
    JAMA Ophthalmol; 2020 Jul 01; 138(7):772-779. PubMed ID: 32463436
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Full-field ERG as a predictor of the natural course of ABCA4-associated retinal degenerations.
    Schroeder M, Kjellström U.
    Mol Vis; 2018 Jul 01; 24():1-16. PubMed ID: 29386879
    [Abstract] [Full Text] [Related]

  • 9. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M, Lambertus S, Mauschitz MM, Bax NM, Kersten E, Lüning A, Nadal J, Schmitz-Valckenberg S, Schmid M, Holz FG, Hoyng CB, Fleckenstein M, Foveal sparing Atrophy Study Team (FAST).
    Invest Ophthalmol Vis Sci; 2017 Feb 01; 58(2):1001-1007. PubMed ID: 28288486
    [Abstract] [Full Text] [Related]

  • 10. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.
    Pilotto E, Convento E, Guidolin F, Abalsamo CK, Longhin E, Parrozzani R, Midena E.
    JAMA Ophthalmol; 2016 Aug 01; 134(8):873-9. PubMed ID: 27253760
    [Abstract] [Full Text] [Related]

  • 11. ASSOCIATION BETWEEN GENOTYPE AND DISEASE PROGRESSION IN ITALIAN STARGARDT PATIENTS: A Retrospective Natural History Study.
    Di Iorio V, Orrico A, Esposito G, Melillo P, Rossi S, Sbordone S, Auricchio A, Testa F, Simonelli F.
    Retina; 2019 Jul 01; 39(7):1399-1409. PubMed ID: 29642238
    [Abstract] [Full Text] [Related]

  • 12. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T, Greenstein VC, Sodi A, Tsang SH, Burke TR, Passerini I, Allikmets R, Virgili G, Cavallini GM, Rizzo S.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul 01; 255(7):1307-1317. PubMed ID: 28365912
    [Abstract] [Full Text] [Related]

  • 13. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP, Progression of Stargardt Disease Study Group.
    Ophthalmology; 2016 Apr 01; 123(4):817-28. PubMed ID: 26786511
    [Abstract] [Full Text] [Related]

  • 14. Morpho-functional analysis of Stargardt Disease for reading.
    Sasso P, Scupola A, Silvestri V, Amore FM, Abed E, Calandriello L, Grimaldi G, Caporossi A.
    Can J Ophthalmol; 2017 Jun 01; 52(3):287-294. PubMed ID: 28576211
    [Abstract] [Full Text] [Related]

  • 15. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA, Leng T.
    Retina; 2014 Aug 01; 34(8):1567-75. PubMed ID: 24743636
    [Abstract] [Full Text] [Related]

  • 16. Clinical and molecular characteristics of childhood-onset Stargardt disease.
    Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K, Robson AG, Holder GE, Allikmets R, Michaelides M, Moore AT.
    Ophthalmology; 2015 Feb 01; 122(2):326-34. PubMed ID: 25312043
    [Abstract] [Full Text] [Related]

  • 17. Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease.
    Anastasakis A, Fishman GA, Lindeman M, Genead MA, Zhou W.
    Retina; 2011 May 01; 31(5):949-58. PubMed ID: 21293320
    [Abstract] [Full Text] [Related]

  • 18. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
    Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN, ProgStar Study Group.
    JAMA Ophthalmol; 2017 Jul 01; 135(7):687-695. PubMed ID: 28542697
    [Abstract] [Full Text] [Related]

  • 19. Fixation behavior in macular dystrophy assessed by microperimetry.
    Chiang WY, Lee JJ, Chen YH, Chen CH, Chen YJ, Wu PC, Fang PC, Kuo HK.
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug 01; 256(8):1403-1410. PubMed ID: 29948177
    [Abstract] [Full Text] [Related]

  • 20. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
    Testa F, Carreño E, van den Born LI, Melillo P, Perea-Romero I, Di Iorio V, Risca G, Iodice CM, Pennings RJE, Karali M, Banfi S, Auricchio A, Galimberti S, Ayuso C, Simonelli F.
    Invest Ophthalmol Vis Sci; 2024 Jun 03; 65(6):25. PubMed ID: 38884554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.